Protective effects of amino acids against Gabexate mesilate-induced cell injury in porcine-aorta endothelial cells

Journal of Pharmacological Sciences

Volumn 107, Issue 3, 2008, Pages 238-245

  Aki, Tomoko ^a   Egashira, Nobuaki ^a   Yamauchi, Yui ^a   Hama, Mika ^a   Yano, Takahisa ^a   Itoh, Yoshinori ^b   Yamada, Takaaki ^a   Oishi, Ryozo ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Amino acid; cytotoxicity; Gabexate mesilate; Vascular endothelial cell; Vascular injury

Indexed keywords

AMINO ACID; CYSTEINE; DICHLOROKYNURENIC ACID; DIZOCILPINE; GABEXATE MESILATE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; ISOLEUCINE; KYNURENIC ACID DERIVATIVE; METHIONINE; PROLINE; PROPIDIUM IODIDE; SERINE; STRYCHNINE; THREONINE; TRYPSIN;

ANIMAL CELL; ARTICLE; BLOOD VESSEL INJURY; CELL DEATH; CELL MEMBRANE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM INJURY; ENZYME INHIBITION; MEMBRANE DAMAGE; NONHUMAN; PROPHYLAXIS; VASCULAR ENDOTHELIUM;

EID: 47749090927     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08053FP     Document Type: Article

References (25)

1. Menegatti E, Bolognesi M, Scalia S, Bortolotti F, Guarneri M, Ascenzi P. Gabexate mesilate inhibition of serine proteases: thermodynamic and computer-graphics analysis. J Pharm Sci. 1986;75:1171-1174.
2. Tamura Y, Hirado M, Okamura K, Minato Y, Fujii S. Synthetic inhibitors of trypsin, plasmin, kallikrein, thorombin, C1r-, and C1 esterase. Biochim Biophys Acta. 1977;484:417-422.
3. Taenaka N, Shimada Y, Hirata T, Nishijima MK, Takezawa J, Yoshiya I, et al. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. Crit Care Med. 1983;11:735-738.
4. Yuasa T, Taniguchi Y, Yamada E, Inachi S, Shimizu M. Severe cutaneous and venous damage after DIC therapy. J Dermatol. 1997;24:466-470.
5. Aki T, Egashira N, Hama M, Yamauchi Y, Yano T, Itoh Y, et al. Characteristics of gabexate mesilate-induced cell injury in porcine aorta endothelial cells. J Pharmacol Sci. 2008;106:415-422.
6. Yata T, Endo Y, Sone M, Ogawara K, Higaki K, Kimura T. Amino acids protect epithelial cells from local toxicity by absorption enhancer, sodium laurate. J Pharm Sci. 2001;90: 1456-1465.
7. Weinberg JM, Varani J, Johnson KJ, Roeser NF, Dame MK, Davis JA, et al. Protection of human umbilical vein endothelial cells by glycine and structurally similar amino acids against calcium and hydrogen peroxide-induced lethal cell injury. Am J Pathol. 1992;140:457-471.
8. Fuller TF, Rose F, Singleton KD, Linde Y, Hoff U, Freise CE, et al. Glutamine donor pretreatment in rat kidney transplants with severe preservation reperfusion injury. J Surg Res. 2007;140:77-83.
9. Nishimura Y, Lemasters JJ. Glycine blocks opening of a death channel in cultured hepatic sinusoidal endothelial cells during chemical hypoxia. Cell Death Differ. 2001;8:850-858.
10. Estacion M, Weinberg JS, Sinkins WG, Schilling WP. Blockade of maitotoxin-induced endothelial cell lysis by glycine and L-alanine. Am J Physiol Cell Physiol. 2003;284:C1006-C1020.
11. Ruiz-Meana M, Pina P, Garcia-Dorado D, Rodríguez-Sinovas A, Barba I, Miró-Casas E, et al. Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition. J Physiol. 2004;558:873-882.
12. Miller GW, Lock EA, Schnellmann RG. Strychnine and glycine protect renal proximal tubules from various nephrotoxicants and act in the late phase of necrotic cell injury. Toxicol Appl Pharmacol. 1994;125:192-197.
13. Gundersen RY, Vaagenes P, Breivik T, Fonnum F, Opstad PK. Glycine - an important neurotransmitter and cytoprotective agent. Acta Anaesthesiol Scand. 2005;49:1108-1116.
14. Ishiyama M, Miyazono Y, Sasamoto K. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 1997;44:1299-1305.
15. Sendo T, Itoh Y, Goromaru T, Sumimura T, Saito M, Aki K, et al. A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. Br J Pharmacol. 2003;138:959-967.
16. Rajendra S, Lynch JW, Schofield PR. The glycine receptor. Pharmacol Ther. 1997;73:121-146.
17. Miller GW, Schnellmann RG. Cytoprotection by inhibition of chloride channels: the mechanism of action of glycine and strychnine. Life Sci. 1993;53:1211-1215.
18. Dong Z, Venkatachalam MA, Weinberg JM, Saikumar P, Patel Y. Protection of ATP-depleted cells by impermeant strychnine derivatives: implications for glycine cytoprotection. Am J Pathol. 2001;158:1021-1028.
19. Pan C, Bai X, Fan L, Ji Y, Li X, Chen Q. Cytoprotection by glycine against ATP-depletion-induced injury is mediated by glycine receptor in renal cells. Biochem J. 2005;390:447-453.
20. Danysz W, Parsons AC. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev. 1998;50:597-664.
21. Herman B, Nieminen AL, Gores GJ, Lemasters JJ. Irreversible injury in anoxic hepatocytes precipitated by an abrupt increase in plasma membrane permeability. FASEB J. 1988;2:146-151.
22. Estacion M, Schilling WP. Maitotoxin-induced membrane blebbing and cell death in bovine aortic endothelial cells. BMC Physiol. 2001;1:2.
23. Schilling WP, Snyder D, Sinkins WG, Estacion M. Palytoxin-induced cell death cascade in bovine aortic endothelial cells. Am J Physiol Cell Physiol. 2006;291:C657-C667.
24. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 1995;146:3-15.
25. Frank A, Rauen U, de Groot H. Protection by glycine against hypoxic injury of rat hepatocytes: inhibition of ion fluxes through nonspecific leaks. J Hepatol. 2000;32:58-66.